Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 41.14 +1.18 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.96 | 52 Week High | $5.17 | |||
| Open | $39.85 | 52 Week Low | $0.94 | |||
| Day High | $41.21 | P/E | N/A | |||
| Day Low | $39.20 | EPS | $0.00 | |||
| Volume | 1,721,675 | |||||
